TherapeuticsMD
TXMD
#10753
Rank
HK$0.15 B
Marketcap
HK$13.64
Share price
1.75%
Change (1 day)
29.94%
Change (1 year)

EPS for TherapeuticsMD (TXMD)

EPS in 2023 (TTM): HK$37.45

According to TherapeuticsMD's latest financial reports the company's current EPS (TTM) is HK$0.63. In 2022 the company made an earnings per share (EPS) of HK$98.40 an increase over its 2021 EPS that were of -HK$170.14.

EPS history for TherapeuticsMD from 1999 to 2023

Annual EPS

Year EPS Change
2023 (TTM)HK$37.45-61.94%
2022HK$98.40-157.83%
2021-HK$170.14-35.22%
2020-HK$262.65-5.63%
2019-HK$278.3320.34%
2018-HK$231.2955.26%
2017-HK$148.97-19.15%
2016-HK$184.25-6%
2015-HK$196.0142.86%
2014-HK$137.2152.17%
2013-HK$90.16-41.03%
2012-HK$152.89-93.62%
2011-HK$2,397-65.57%
2010-HK$6,96388.66%
2009-HK$3,691-32.78%
2008-HK$5,49116.59%
2007-HK$4,70926.96%
2006-HK$3,709-11743.27%
2005HK$31.86-101.88%
2004-HK$1,694-554.77%
2003HK$372.43216.55%
2002HK$117.65-85.01%
2001HK$784.91369.94%
2000HK$167.02404.51%
1999HK$33.11

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
HK$5.96 850.00%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$27.99 4,363.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Agile Therapeutics
AGRX
-HK$30.34-4,937.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
HK$14.71 2,244.83%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lannett Company
LCI
-HK$198.20-31,700.00%๐Ÿ‡บ๐Ÿ‡ธ USA